GSK
835 hedge funds and large institutions have $11.6B invested in GSK in 2024 Q4 according to their latest regulatory filings, with 105 funds opening new positions, 283 increasing their positions, 319 reducing their positions, and 149 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
835
Holders Change
-56
Holders Change %
-6.29%
% of All Funds
11.12%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
105
Increased
283
Reduced
319
Closed
149
Calls
$460M
Puts
$105M
Net Calls
+$355M
Net Calls Change
+$258M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$805M |
| 2 |
Primecap Management
Pasadena,
California
|
+$352M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$197M |
| 4 |
Goldman Sachs
New York
|
+$78.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$68.2M |
Top Sellers
| 1 |
PTC
Provident Trust Company
Waukesha,
Wisconsin
|
-$162M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$123M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$92.9M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
-$86M |
| 5 |
Morgan Stanley
New York
|
-$75.3M |
